Proof-of-concept trial of ARRY-380 in patients with metastatic breast cancer, including patients with brain metastases

Trial Profile

Proof-of-concept trial of ARRY-380 in patients with metastatic breast cancer, including patients with brain metastases

Planning
Phase of Trial: Phase I

Latest Information Update: 09 Aug 2013

At a glance

  • Drugs Tucatinib (Primary)
  • Indications Advanced breast cancer; Brain metastases
  • Focus Therapeutic Use
  • Sponsors Cascadian Therapeutics
  • Most Recent Events

    • 09 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top